Impact of Mindful Walking Intervention on Daily Step Count

Sponsor
Clemson University (Other)
Overall Status
Completed
CT.gov ID
NCT03856385
Collaborator
(none)
40
1
2
2.7
15

Study Details

Study Description

Brief Summary

Mindful walking is a meditation practice that combines physical activity and mindfulness practice. This study examined whether a mindful walking intervention increased physical activity and improved health outcomes. The investigators conducted a randomized experiment among adults with inadequate physical activity, whereby the intervention group received a four-week, one-hour-per-week mindful walking intervention and the control group received instructions to increase physical activity (N=38). Participants in both groups received a wrist-worn step count device as participation incentive. Physical activity and health outcomes were measured with an online survey and data obtained from the wearable device at baseline (T1), post-intervention (T2), and one month after the intervention (T3).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindful Walking
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Impact of Mindful Walking Intervention on Daily Step Count: A Pilot Study
Actual Study Start Date :
May 26, 2017
Actual Primary Completion Date :
Aug 15, 2017
Actual Study Completion Date :
Aug 15, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindful Walking

Four weekly 60 minute sessions of mindful walking.

Behavioral: Mindful Walking
Weekly 60 minute mindful walking sessions involving observations of bodily sensations, experiences, and breath. Discussion of mindful walking experiences and encouragement to meet physical activity goals.

No Intervention: Control

Weekly email messages encouraging physical activity.

Outcome Measures

Primary Outcome Measures

  1. Rapid Assessment of Physical Activity Scale [one week]

    self-report scale of physical activity, with total score ranging from 1-10; higher scores indicate increased activity

  2. Daily Step Counts [one day]

    Fitbit-HR device data

  3. Screen Time [one week]

    self-report measure, 4 items assessing television and non-television time in number of hours

Secondary Outcome Measures

  1. Perceived Stress Scale [one month]

    self-report measure, total score ranges from 4 to 20, higher levels indicating higher levels of stress

  2. Mental Health Inventory [one month]

    self-report measure of health-related quality of life, total score ranging from 5 to 30, with higher levels indicating higher quality of life

  3. Brief Edinburgh Depression Scale [7 days]

    self-report measure, total score ranging from 6 to 24, with higher levels indicating higher levels of depression symptoms

  4. Freiburg Mindfulness Inventory [7 days]

    self-report measure, total score ranging from 14 to 56 with higher scores indicating higher levels of mindfulness skills

  5. Pittsburgh Sleep Quality Index [one month]

    self-report measure, total score ranging from 7 to 28, with higher scores indicating worse sleep quality

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults over age 18

  • Able to read and understand English

Exclusion Criteria:
  • Student athletes

  • Medical condition that limits slow-paced walking for 20 minutes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clemson University Clemson South Carolina United States 29634

Sponsors and Collaborators

  • Clemson University

Investigators

  • Principal Investigator: Lu Shi, Ph.D., Clemson University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Heidi Zinzow, Associate Professor, Clemson University
ClinicalTrials.gov Identifier:
NCT03856385
Other Study ID Numbers:
  • IRB2017-099
First Posted:
Feb 27, 2019
Last Update Posted:
Feb 27, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 27, 2019